CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- 4 Open-market sale EVP, Head of Development & CMO sold 60,000 shares at an average $26.07 ($1,564,057)
- 4 Open-market sale EVP, Chief Business Officer sold 1,477 shares at $25.00 ($36,925)
- 4 Open-market sale EVP, Chief Business Officer sold 64,671 shares at an average $25.01 ($1,617,491)
- 4 Open-market sale EVP, Chief Business Officer sold 8,658 shares at an average $25.00 ($216,468)
- 4 Open-market sale EVP, Chief Business Officer sold 4,136 shares at an average $25.01 ($103,421)
- 4 Open-market sale EVP, Chief Business Officer sold 2,300 shares at an average $25.01 ($57,533)
- 4 Other acquisition Director acquired 12,500 shares (other)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 43,750,000 shares (conversion)
- 4 Conversion 10% owner acquired 43,750,000 shares (conversion)
- 4 Conversion Director acquired 2,031,250 shares (conversion)
Page 8 of 10 · 193 filings